Related Experiment Video
Updated: Jun 3, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Advancement of the Dragon Heart 7-Series for Pediatric Patients With Heart Failure
Giselle C Matlis1, Thomas C Palazzolo1, Jonathan E M Lawley2,3
1BioCirc Research Laboratory, School of Biomedical Engineering, Science, and Health Systems, Drexel University, Philadelphia, Pennsylvania, USA.
Insights
Developing the Dragon Heart (DH) pediatric total artificial heart (TAH) shows promise. Computational modeling and prototype testing confirm its centrifugal pump meets pressure-flow requirements for pediatric use.
Area of Science:
- Biomedical Engineering
- Cardiovascular Devices
- Pediatric Cardiology
Background:
- Pediatric blood pumps lag behind adult devices, creating a critical clinical need.
- A novel hybrid total artificial heart (TAH), the Dragon Heart (DH), is under development.
- The DH integrates axial and centrifugal pumps in a compact, magnetically levitated design.
Purpose of the Study:
- To computationally model and experimentally validate the centrifugal pump component of the pediatric TAH (Dragon Heart).
- To assess the DH centrifugal pump's ability to meet pediatric pressure and flow requirements.
- To identify areas for design improvement, specifically regarding fluid stress and hemolytic potential.
Main Methods:
- Computational modeling was used to iteratively refine the DH centrifugal pump design.
- Key performance metrics including pressure generation and fluid forces were estimated.
- A prototype centrifugal pump was manufactured and tested using a blood analog in a hydraulic flow loop.
Main Results:
- The DH centrifugal pump design achieved target pressures of 60-140 mmHg at flow rates of 1-5 L/min.
- Experimental data showed strong agreement (<10% deviation) with computational pressure rise predictions.
- Elevated fluid stress levels were observed in the outflow region, with residence times under 600 ms.
Conclusions:
- The compact, next-generation Dragon Heart centrifugal pump design meets essential pressure-capacity requirements for pediatric TAH applications.
- Further development is necessary to mitigate hemolytic potential.
- Integration of magnetic suspension for full rotor levitation is a key next step.
Background:
Safe and effective pediatric blood pumps continue to lag far behind those developed for adults. To address this growing unmet clinical need, we are developing a hybrid, continuous-flow, magnetically levitated, pediatric total artificial heart (TAH). Our hybrid TAH design, the Dragon Heart (DH), integrates both an axial flow and centrifugal flow blood pump within a single, compact housing. The axial pump is embedded in the central hub region of the centrifugal pump, and both pumps rotate around a common central axis, while maintaining separate fluid domains.
Methods:
In this work, we concentrated our design and development effort on the centrifugal blood pump by performing computational modeling. An iterative process was employed to improve the DH design. The pressure generation, scalar stress levels, and fluid forces exerted on the magnetically levitated impellers were computationally estimated. A shaft driven centrifugal prototype was also manufactured and tested using a hydraulic flow loop circulating a water-glycerol blood analog. Pressure and flow performance of the pump prototype was measured for a given rotational speed for comparison to computational predictions.
Results:
Our design achieved the target pump pressures of 60-140 mm Hg for flow rates of 1-5 L/min, and strong agreement in pressure rise was demonstrated between the experimental data and simulation results (less than 10% deviation on average). Fluid stress levels were, however, found to exceed thresholds in the outflow region of the pump, and fluid residence times were less than 600 ms.
Conclusion:
The findings of this work demonstrate that the more compact, next-gen DH's centrifugal pump design is able to achieve pressure-capacity requirements. Next steps will require a focused strategy to reduce hemolytic potential and to integrate magnetic suspension components for full rotor levitation.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: β-Blockers
Pathophysiology of Heart Failure
Development of the Heart
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

